Generic name: docusate sodium, ascorbic acid, .alpha.-tocopherol acetate, dl-, thiamine mononitrate, riboflavin, niacinamide, pyridoxine hydrochloride, folic acid, cholecalciferol, calcium citrate, iron, potassium iodide, zinc oxide and cupric oxide
Dosage form: tablet, film coated
Drug class: Iron products, Vitamin and mineral combinations
Medically reviewed by Drugs.com. Last updated on Dec 22, 2020.
Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
On This Page
Each Vinacal™ tablet contains:
Vitamin C (as Ascorbic Acid).....120 mg
Vitamin D3 (Cholecalciferol) .....400 IU
Vitamin E (as dl-Alpha Tocopheryl Acetate).....30 IU
Vitamin B1 (as Thiamine Mononitrate) .....3 mg
Vitamin B2 (Riboflavin) .....3.4 mg
Niacinamide (Vitamin B3) .....20 mg
Vitamin B6 (as Pyridoxine HCl) .....20 mg
Folic Acid .....1 mg
Calcium (as Calcium Citrate) .....125 mg
Iron (as Carbonyl Iron and Ferrous Gluconate) .....27 mg
Iodine (as Potassium Iodide).....150 mcg
Zinc (as Zinc Oxide) .....25 mg
Copper (as Cupric Oxide) .....2 mg
Docusate Sodium .....50 mg
Inactive Ingredients: Citric Acid, Croscarmellose Sodium, Crospovidone, Dicalcium Phosphate, Gelatin, Hypromellose, Magnesium Silicate, Magnesium Stearate, Microcrystalline Cellulose, Mineral Oil, Polyvinylpyrrolidone, Silica, Sodium Ascorbate, Sodium Benzoate, Sodium Lauryl Sulfate, Sorbic Acid, Soy Polysaccharide, Starch, Stearic Acid, Sucrose, Titanium Dioxide, Triacetin, Triglycerides and Tocopherols.
Allergen: Contains Soy
Vinacal™ Tablets are a multivitamin/multimineral tablet, for use in supplementing the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers.
Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.
Keep this and all medications out of the reach of children.
If pregnant, or planning to become pregnant or are currently breast-feeding, please contact your physician, or health-care provider before using or continuing use.
Contact with moisture can produce surface discoloration or erosion of the tablet.
Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive.
Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
Folic Acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.
Vinacal Dosage and Administration
One tablet daily, or as directed by a physician.
All iron compounds are contraindicated in patients with hemochromatosis and hemosiderosis. This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.
How is Vinacal Supplied
Vinacal™ Tablets are available as a scored, white film-coated, oval shaped tablet debossed B 617 on one side and blank on the other. Supplied in bottles of 90, NDC 51991-617-90.
Store at 25°C (77°F); excursions permitted to 15°- 30°C (59°- 86°F). See USP Controlled Room Temperature.
Protect from light and moisture.
Dispense in a tight, light-resistant container with a child-resistant closure as defined in the USP/NF.
All prescription substitutions using this product shall be pursuant to state statutes as applicable. This is not an Orange Book product.
Breckenridge Pharmaceutical, Inc.
Boca Raton, FL 33487
Contract Pharmacal Corp.
Hauppauge, NY 11788 USA
PRINCIPAL DISPLAY PANEL - 90 Tablet Bottle
DO NOT USE IF SAFETY SEAL UNDER THE CAP
IS BROKEN OR MISSING
docusate sodium, ascorbic acid, .alpha.-tocopherol acetate, dl-, thiamine mononitrate, riboflavin, niacinamide, pyridoxine hydrochloride, folic acid, cholecalciferol, calcium citrate, iron, potassium iodide, zinc oxide, and cupric oxide tablet, film coated
|Labeler - Breckenridge Pharmaceutical, Inc. (150554335)|
|Contract Pharmacal Corporation||057795122||MANUFACTURE|